This work is licensed under the Creative Commons Attribution 4.0 International License.
Shin DW, Moon SH, Kim JH. Diagnosis of cholangiocarcinoma. Diagnostics (Basel). 2023; 13:233.ShinDWMoonSHKimJHDiagnosis of cholangiocarcinomaDiagnostics (Basel)202313233Search in Google Scholar
Kendall T, Verheij J, Gaudio E, Evert M, Guido M, Goeppert B, Carpino G. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 2019; 39(Suppl 1):7–18.KendallTVerheijJGaudioEEvertMGuidoMGoeppertBCarpinoGAnatomical, histomorphological and molecular classification of cholangiocarcinomaLiver Int201939Suppl 1718Search in Google Scholar
Lalani T, Couto CA, Rosen MP, Baker ME, Blake MA, Cash BD, et al. ACR appropriateness criteria jaundice. J Am Coll Radiol. 2013; 10:402–9.LalaniTCoutoCARosenMPBakerMEBlakeMACashBDACR appropriateness criteria jaundiceJ Am Coll Radiol2013104029Search in Google Scholar
Shen WF, Zhong W, Xu F, Kan T, Geng L, Xie F, et al. Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma. World J Gastroenterol. 2009; 15:5976–82.ShenWFZhongWXuFKanTGengLXieFClinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinomaWorld J Gastroenterol200915597682Search in Google Scholar
Pabst KM, Trajkovic-Arsic M, Cheung PFY, Ballke S, Steiger K, Bartel T, et al. Superior tumor detection for 68Ga-FAPI-46 versus 18F-FDG PET/CT and conventional CT in patients with cholangiocarcinoma. J Nucl Med. 2023; 64:1049–55.PabstKMTrajkovic-ArsicMCheungPFYBallkeSSteigerKBartelTSuperior tumor detection for 68Ga-FAPI-46 versus 18F-FDG PET/CT and conventional CT in patients with cholangiocarcinomaJ Nucl Med202364104955Search in Google Scholar
Labib PL, Goodchild G, Pereira SP. Molecular Pathogenesis of cholangiocarcinoma. BMC Cancer. 2019; 19:185. doi: 10.1186/s12885-019-5391-0LabibPLGoodchildGPereiraSPMolecular Pathogenesis of cholangiocarcinomaBMC Cancer20191918510.1186/s12885-019-5391-0Open DOISearch in Google Scholar
Lu S, Li J. Treatment of cholangiocarcinoma by pGCsiRNA-vascular endothelial growth factor in vivo. Asian Biomed (Res Rev News). 2024; 18:61–8.LuSLiJTreatment of cholangiocarcinoma by pGCsiRNA-vascular endothelial growth factor in vivoAsian Biomed (Res Rev News)202418618Search in Google Scholar
Elvevi A, Laffusa A, Scaravaglio M, Rossi RE, Longarini R, Stagno AM, et al. Clinical treatment of cholangiocarcinoma: an updated comprehensive review. Ann Hepatol. 2022; 27:100737. doi: 10.1016/j.aohep.2022.100737ElveviALaffusaAScaravaglioMRossiRELongariniRStagnoAMClinical treatment of cholangiocarcinoma: an updated comprehensive reviewAnn Hepatol20222710073710.1016/j.aohep.2022.100737Open DOISearch in Google Scholar